This inventor holds 1 USPTO granted patent. Top assignee: Xtl Biopharmaceuticals Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jie Cao - Innovator in HCV Treatment
Introduction
Jie Cao is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). His innovative work has led to the development of new compounds that hold promise for effective antiviral therapies.
Latest Patents
Jie Cao holds a patent for 4-ethynyl pyrazole derivative compounds and methods for the treatment of HCV. This patent includes aryl substituted pyrazole derivatives and outlines processes for their preparation. The invention also provides compositions and methods for treating HCV by administering a compound of the present invention, either alone or in combination with additional antiviral agents, in a therapeutically effective amount. He has 1 patent to his name.
Career Highlights
Cao is associated with XTL Biopharmaceuticals Ltd., where he continues to advance research in antiviral treatments. His work is characterized by a commitment to developing innovative solutions for complex health challenges.
Collaborations
Some of his notable coworkers include Guolin Li and Reza Fathi, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Jie Cao's contributions to the field of biopharmaceuticals, particularly in HCV treatment, highlight his role as an innovative inventor. His work continues to pave the way for advancements in antiviral therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile